Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interferon (IFN) signaling pathway is a critical component of the innate and adaptive immune response. It is activated by the binding of IFNs to their respective receptors, leading to the activation of the JAK-STAT signaling cascade and the subsequent transcription of interferon-stimulated genes (ISGs). This pathway plays a crucial role in antiviral defense, antitumor immunity, and the regulation of inflammation. Defects in the IFN pathway are frequently observed in cancer cells, leading to immune evasion and resistance to therapy. Targeting the IFN pathway or restoring its function is an area of active investigation for cancer therapeutics.
Activation of JAK-STAT signaling pathway, leading to the transcription of interferon-stimulated genes (ISGs).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon Signaling Pathway (IFN Pathway).